Atorvastatin added to interferon beta for relapsing multiple sclerosis: 12-month treatment extension of the randomized multicenter SWABIMS trial.

by Christian P Kamm, Marwan El-Koussy, Sebastian Humpert, Oliver Findling, Yuliya Burren, Guido Schwegler, Filippo Donati, Martin Müller, Felix Müller, Johannes Slotboom, Ludwig Kappos, Yvonne Naegelin, Heinrich P Mattle, SWABIMS Study Group
Published 2014-01-01